Inventor
ROSENBLUM MICHAEL G
US28 patents
⚠️ This page may combine multiple inventors who share the name “ROSENBLUM MICHAEL G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RES DEV FOUNDATION
18 patentsUS6750329B1Jun 15, 2004
Antibody delivery system for biological response modifiers
RES DEV FOUNDATION62 citations95
US5624827AApr 29, 1997
DNA sequences encoding the plant toxin gelonin
RES DEV FOUNDATION60 citations95
US6214974B1Apr 10, 2001
Avidin-biotin immunoconjugates
RES DEV FOUNDATION53 citations94
US8043831B2Oct 25, 2011
Therapeutic agents comprising pro-apoptotic proteins
RES DEV FOUNDATION12 citations92
US7759091B2Jul 20, 2010
Therapeutic agents comprising pro-apoptotic proteins
RES DEV FOUNDATION10 citations92
US7101977B2Sep 5, 2006
Therapeutic agents comprising pro-apoptotic proteins
RES DEV FOUNDATION27 citations92
US7083957B2Aug 1, 2006
Modified proteins, designer toxins, and methods of making thereof
RES DEV FOUNDATION28 citations92
US6599505B1Jul 29, 2003
Immunotoxins directed against CD33 related surface antigens
RES DEV FOUNDATION34 citations92
US6306626B1Oct 23, 2001
Anti-IgM monoclonal antibodies and methods of their use
RES DEV FOUNDATION23 citations91
US6669938B1Dec 30, 2003
ImmunoConjucates for cancer diagnosis and therapy
RES DEV FOUNDATION25 citations87
US9096840B2Aug 4, 2015
Serine protease molecules and therapies
RES DEV FOUNDATION9 citations82
US7943571B2May 17, 2011
Modified proteins, designer toxins, and methods of making thereof
RES DEV FOUNDATION6 citations73
US7741278B2Jun 22, 2010
Modified proteins, designer toxins, and methods of making thereof
RES DEV FOUNDATION4 citations73
US7371723B2May 13, 2008
Therapeutic agents comprising pro-apoptotic proteins
RES DEV FOUNDATION4 citations73
US7285635B2Oct 23, 2007
Modified proteins, designer toxins, and methods of making thereof
RES DEV FOUNDATION4 citations73
US7297335B2Nov 20, 2007
Immunotoxins directed against CD33 related surface antigens
RES DEV FOUNDATION3 citations63
US9388397B2Jul 12, 2016
Deimmunized gelonin molecules and therapies
RES DEV FOUNDATION2 citations62
US9499807B2Nov 22, 2016
Serine protease molecules and therapies
RES DEV FOUNDATION0 citations50
RES FOUND DEV
5 patentsUS11535838B2Dec 27, 2022
Serine protease molecules and therapies
RES FOUND DEV3 citations82
US10323239B2Jun 18, 2019
Serine protease molecules and therapies
RES FOUND DEV4 citations82
US9951325B2Apr 24, 2018
Serine protease molecules and therapies
RES FOUND DEV4 citations82
US10920211B2Feb 16, 2021
Serine protease molecules and therapies
RES FOUND DEV1 citations71
US10738295B2Aug 11, 2020
Serine protease molecules and therapies
RES FOUND DEV1 citations71